IRIS
GALIERO, RAFFAELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.135
AS - Asia 1.570
NA - Nord America 1.146
SA - Sud America 201
Continente sconosciuto - Info sul continente non disponibili 78
AF - Africa 18
Totale 6.148
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 2.538
US - Stati Uniti d'America 1.109
SG - Singapore 485
CN - Cina 348
VN - Vietnam 249
IT - Italia 239
HK - Hong Kong 232
BR - Brasile 168
IE - Irlanda 123
KR - Corea 79
DE - Germania 72
IN - India 72
GB - Regno Unito 31
JP - Giappone 27
FR - Francia 23
NL - Olanda 16
MX - Messico 14
CA - Canada 13
PL - Polonia 13
AT - Austria 11
BD - Bangladesh 11
ID - Indonesia 11
FI - Finlandia 10
AR - Argentina 9
LT - Lituania 8
ZA - Sudafrica 8
AE - Emirati Arabi Uniti 7
CZ - Repubblica Ceca 7
TR - Turchia 7
UA - Ucraina 7
CO - Colombia 6
PK - Pakistan 6
EC - Ecuador 5
PT - Portogallo 5
SE - Svezia 5
VE - Venezuela 5
CH - Svizzera 4
CR - Costa Rica 4
ES - Italia 4
IL - Israele 4
IQ - Iraq 4
MA - Marocco 4
SA - Arabia Saudita 4
BE - Belgio 3
BO - Bolivia 3
IR - Iran 3
PE - Perù 3
AZ - Azerbaigian 2
EG - Egitto 2
GE - Georgia 2
GR - Grecia 2
JM - Giamaica 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
MO - Macao, regione amministrativa speciale della Cina 2
RO - Romania 2
RS - Serbia 2
SI - Slovenia 2
UZ - Uzbekistan 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DM - Dominica 1
EE - Estonia 1
ET - Etiopia 1
HN - Honduras 1
HR - Croazia 1
JO - Giordania 1
LB - Libano 1
LV - Lettonia 1
MU - Mauritius 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PY - Paraguay 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TW - Taiwan 1
UY - Uruguay 1
Totale 6.070
Salva come PNG Salva come JPEG
Città #
Moscow 906
San Jose 249
Singapore 243
Hong Kong 224
Santa Clara 130
Dublin 117
Hefei 98
Ashburn 94
The Dalles 82
Seoul 79
Naples 74
Ho Chi Minh City 73
New York 58
Hanoi 56
Bengaluru 47
Chandler 43
Munich 35
Los Angeles 34
Beijing 33
Dallas 24
Da Nang 20
São Paulo 20
Memphis 14
Orem 14
Haiphong 12
Amsterdam 11
Chicago 10
Atlanta 9
Avellino 9
Milan 9
Salerno 9
Falkenstein 8
Frankfurt am Main 8
Hillsboro 8
Hải Dương 8
Belo Horizonte 7
Brooklyn 7
Liveri 7
Mexico City 7
Warsaw 7
Bexley 6
Biên Hòa 6
Boardman 6
Cambridge 6
Chennai 6
Florence 6
Princeton 6
Roxbury 6
Vienna 6
Brno 5
Bến Tre 5
Denver 5
Ercolano 5
Helsinki 5
Johannesburg 5
Lahore 5
Manchester 5
Nuremberg 5
San Francisco 5
Stockholm 5
Tokyo 5
Boston 4
Bắc Ninh 4
Guarulhos 4
Istanbul 4
Lisbon 4
Montreal 4
Paris 4
Pelotas 4
Rio de Janeiro 4
San José 4
Shanghai 4
Toronto 4
Wroclaw 4
Yên Bái 4
Zurich 4
Boydton 3
Brasília 3
Bremen 3
Brussels 3
Bắc Giang 3
Campinas 3
Can Tho 3
Cape Town 3
Council Bluffs 3
La Paz 3
Lappeenranta 3
London 3
Mumbai 3
New Delhi 3
Nha Trang 3
Ninh Bình 3
Olbia 3
Porto Alegre 3
Rome 3
Shenzhen 3
Tel Aviv 3
Terzigno 3
Thanh Mỹ Tây 3
The Bronx 3
Totale 3.149
Salva come PNG Salva come JPEG
Nome #
Cardiac Hypertrophy: from Pathophysiological Mechanisms to Heart Failure Development 197
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 184
Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study 159
ULTRASOUND TIPS IN THE LUNG CANCER DIAGNOSIS: A PILOT STUDY 159
Left bundle branch pacing and cardiac remodeling in HF patients with type 2 diabetes mellitus: epigenetic pathways and clinical outcomes 157
Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes 155
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options 152
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes 151
Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options 151
GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives 146
Comment on: Effect of Vitamin D supplementation in patients with liver cirrhosis having spontaneous bacterial peritonitis: a randomized controlled study 142
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 140
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 133
Liver Involvement in Patients With Systemic Sclerosis: Role of Transient Elastography in the Assessment of Hepatic Fibrosis and Steatosis 133
An Update on Betrixaban, the Challenging Anticoagulant Agent for Extended Venous Thromboembolism Prophylaxis 131
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study 131
Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy 131
Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease 130
CURRENT HEPATOCELLULAR CARCINOMA SYSTEMIC PHARMACOLOGICAL TREATMENT OPTIONS 127
Comment on: Warfarin adherence and anticoagulation control in atrial fibrillation patients-a systematic review 127
EFFICACY OF COVID-19 VACCINATION IN PATIENTS WITH IMMUNE SYSTEM DISORDERS AND CANCER 125
Sex-difference of multifactorial intervention on cardiovascular and mortality risk in DKD: post-hoc analysis of a randomised clinical trial 125
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial 125
Advances in the Insulin-Heart Axis: Current Therapies and Future Directions 124
Effects of Metformin in Heart Failure: From Pathophysiological Rationale to Clinical Evidence 120
Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications 119
Diabetic Gastroparesis: Navigating Pathophysiology and Nutritional Interventions 117
Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies 116
Changes in clinical scenarios, management, and perspectives of patients with chronic hepatitis C after viral clearance by direct-acting antivirals 116
Advances in Pharmacological Approaches for Managing Hypercholesterolemia: A Comprehensive Overview of Novel Treatments 113
Cardiovascular Benefits from Gliflozins: Effects on Endothelial Function 112
ULTRASOUND TIPS IN THE LUNG CANCER DIAGNOSIS: A PILOT STUDY 112
The Significance of Statin-Associated Muscle Symptoms and Its Impact on Patient Adherence and Outcomes 111
Modern Challenges in Type 2 Diabetes: Balancing New Medications with Multifactorial Care 110
Optimizing Anticoagulation Management in Atrial Fibrillation: Beyond the Guidelines. How and for Whom? 109
Polypharmacy and major adverse events in atrial fibrillation 108
Assessment of the Effectiveness of Ticagrelor Preloading in Mitigating Periprocedural Myocardial Injury Among Non-ST Elevation Myocardial Infarction Patients Opting for an Early Invasive Approach 108
Late Hepatocellular Carcinoma Occurrence in Patients Achieving Sustained Virological Response After Direct-Acting Antiviral Therapy: A Matter of Follow-Up or Something Else? 104
Predictive Value of Fatty Liver Index for Long-Term Cardiovascular Events in Patients Receiving Liver Transplantation: The COLT Study 99
NerveCheck master to screen patients with type 1 or type 2 diabetes for peripheral and cardiac autonomic neuropathy 99
The Role of Neuropathy Screening Tools in Patients Affected by Fibromyalgia 97
null 93
Insulin–Heart Axis: Bridging Physiology to Insulin Resistance 92
Saxagliptin/dapagliflozin is non‐inferior to insulin glargine in terms of β‐cell function in subjects with latent autoimmune diabetes in adults: A 12‐month, randomized, comparator‐controlled pilot study 91
The Role of Lung Ultrasound in SARS-CoV-19 Pneumonia Management 90
The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms 88
Impact of Gliflozins on Right Heart Remodeling in Italian Patients with Type 2 Diabetes and Heart Failure: Results from the GLISCAR Real-World Study 85
Does a strict glycemic control during acute coronary syndrome play a cardioprotective effect? Pathophysiology and clinical evidence 82
Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations 79
Impact of empagliflozin as add-on to metformin vs metformin continuation on MASLD progression in type 2 diabetes: The IMAGIN Study 72
Remdesivir treatment and clinical outcome in non-severe hospitalized COVID-19 patients: a propensity score matching multicenter Italian hospital experience 71
Totale 6.148
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.257
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.257
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202245 0 0 0 2 2 0 2 1 9 1 8 20
2022/2023221 11 12 4 10 27 11 5 8 105 10 7 11
2023/2024276 26 13 9 24 51 45 8 9 7 25 26 33
2024/2025967 4 14 3 24 154 95 123 92 164 102 88 104
2025/20264.600 247 300 240 145 401 2.333 318 203 165 103 90 55
2026/202738 32 6 0 0 0 0 0 0 0 0 0 0
Totale 6.148